.
One of the fundamental problems in cardiovascular research is concerned with the relation between biochemical energy provision and demand of the myocardium in healthy and diseased states. Until recently most of the available biochemical information was a result of indirect or highly invasive measurements. During the past nine years we have shown that nuclear magnetic resonance spectroscopy is a powerful tool for the study of tissue energetics' and have developed techniques for the study of isolated and in vivo organs in animals2 and more recently in man. 3 Nuclear magnetic resonance is observed as a very weak response when chemical substances are placed in a strong uniform magnetic field and are irradiated with weak radiofrequency waves. It arises from the interaction of atomic nuclei with the applied magnetic field and yields detailed information abdtt chemical structures and molecular motions. Only (Fig. 1) .
The key role of adenosine triphosphate in providing the energy for work is assured by adequate provisions for maintaining its concentration through three sepaBassd on the Bntish Heart Foundation prize lecture delivered at the meeting of the Briish Cardiac Society, 7 December 1982 Mitochondrion gl ycogen -* *lactte glycolysi s Fig. 1 Energetics in heart and muscle (ADP, adenosine diphosphate; PCr, phosphocreatine; ATP, adenosine triphosphate). rate but closely interlinked reactions: (a) oxidative ohosphorylation, (b) the rapid conversion of phosphocreatine to adenosine triphosphate, and (c) anaerobic degradation of glycogen to lactic acid. The fluxes through the different pathways are controlled in several ways and the switch from aerobic to anaerobic production of adenosine triphosphate involves a complex series of reactions catalysed by a cascade of enzymes in which Ca++ has a special role. Lactate production is accompanied by cellular acidification, particularly under conditions of restricted flow, and as a result is believed to contribute to irreversible damage during cardiac ischaemia.
In my view it is inconceivable that knowledge of the concentrations of high energy phosphates, the fluxes through the various reactions shown in Fig. 1 Fig. 2 shows a typical p nuclear magnetic resonance spectrum obtained from an isolated perfused rat heart. The chemical responsible for each resonance can be identified from the frequency of the signal while the area under each peak gives a direct measure of the amount of the corresponding compound present in the sample. We can also find out something' about intermolecular interactions, environment, and molecular motion from measurements of line widths and relaxation indices. Simultaneously, from the position of the signal from inorganic phosphate we can derive the value of intracellular cytoplasmic pH.
For example, during cardiac arrest (which we can simulate in the isolated heart by inducing total global ischaemia) we observe the rapid depletion of phosphocreatine (in less than 4 minutes at 3QC), the build up of inorganic phosphate, and intracellular acidification. Decrease in adenosine triphosphate is observed only after all the phosphocreatine has been used up. The time course of changes in metabolites can thus be rapidly followed both in the early stages of ischaemia and during recovery brought about by reperfusion.s During a 12 to 15 minute period of total global ischaemia intracellular pH decreases from 705 to 6*4. It has cften been suggested that high acidity can lead to irreversible damage during ischaemia. Our studies suggest that while the ischaemic myocardium can be protected by good extnal buffering, which reduces intracellular acidosis,6 low pH alone does not Radda account for irreversible damage. For example, in hearts treated with insulin before global ischaemia, intracellular pH decreases to as low a value as 5.9 yet functional and metabolic recovery is observed after reflow. This is because adenosine triphosphate is maintained by increasing glycogenolysis.7 This observation illustrates how 31p nuclear magnetic resonance can be used to study tissue protection. In addition, "well established" ideas can now be directly tested; in this case the demonstration that glycogenolysis proceeds rapidly even though the intracellular pH decreased to well below 6-3 is unexpected and contrary to established views about the inhibition of phosphofructokinase at low pH.
REACTION FLUXES: IN VIVO ENZYMOLOGY
A unique aspect of in vivo nuclear magnetic resonance spectroscopy is that the fluxes of intracellular enzyme catalysed reactions can be measured even when the system is in equilibrium or a steady state. Fig. 3 illustrates the method of saturation transfer. approach is to localise the spectroscopic observations to a defined volume element within the subject to be examined. So far, two main methods of localising 31p nuclear magnetic resonance measurements have been used: surface coils'0 and field profiling (focusing)." These techniques (or a combination of the two) have been used in examining the biochemical energetics of skeletal muscle, brain, heart, liver, and kidney in laboratory animals and of skeletal muscle in humans.
In animal models, for example, the time course of metabolic changes in the heart following respiratory arrest has been examined (Fig. 4) In one patient we examined the metabolic consequ-)lying that ences of treatment with verapamil and found restoracise is stop-tion of some control function possibly associated with his and pre-intracellular Ca++. Potential and limitations of nuclear magnetic resonance for the cardiologist Study of human heart disease The technology to observe 31p nuclear magnetic resonance spectra in the human heart is now available and clinical studies will soon begin. It is important that we explore this new technique in relation to existing clinical methods, yet at the same time realise that it gives us a new approach to human investigations. It tells us about the biochemistry of the tissue, albeit at relatively low spatial resolution. Because of these, and because the measurements can be repeated, new tests can be designed to elucidate the basis of the disorder and to develop or monitor treatment. Thus the technique should not be looked on as yet another expensive diagnostic imaging technique but as a way of providing an objective and rational approach to clinical research and patient management. In my view, this technique cannot fail to enhance our understanding of cardiomyopathies or to contribute to clinical evaluations of the salvaging or correction of ischaemic heart disease.
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